BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ranucci R. Cell-Free DNA: Applications in Different Diseases. Methods Mol Biol 2019;1909:3-12. [PMID: 30580419 DOI: 10.1007/978-1-4939-8973-7_1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Karakousis ND, Chrysavgis L, Papatheodoridi A, Legaki A, Lembessis P, Cholongitas E, Chatzigeorgiou A, Papatheodoridis G. Significance of Circulating Cell-Free DNA Biomarkers in HBeAg-Negative Chronic Hepatitis B Virus Infection and Their Changes after Treatment Initiation. Pathogens 2023;12:394. [DOI: 10.3390/pathogens12030394] [Reference Citation Analysis]
2 Fertan E, Gendron WH, Wong AA, Hanson GM, Brown RE, Weaver ICG. Noncanonical regulation of imprinted gene Igf2 by amyloid-beta 1-42 in Alzheimer's disease. Sci Rep 2023;13:2043. [PMID: 36739453 DOI: 10.1038/s41598-023-29248-x] [Reference Citation Analysis]
3 Pietrzak B, Kawacka I, Olejnik-Schmidt A, Schmidt M. Circulating Microbial Cell-Free DNA in Health and Disease. Int J Mol Sci 2023;24. [PMID: 36769374 DOI: 10.3390/ijms24033051] [Reference Citation Analysis]
4 El Hejjioui B, Bouguenouch L, Melhouf MA, El Mouhi H, Bennis S. Clinical Evidence of Circulating Tumor DNA Application in Aggressive Breast Cancer. Diagnostics (Basel) 2023;13. [PMID: 36766575 DOI: 10.3390/diagnostics13030470] [Reference Citation Analysis]
5 Tierno D, Grassi G, Zanconati F, Bortul M, Scaggiante B. An Overview of Circulating Cell-Free Nucleic Acids in Diagnosis and Prognosis of Triple-Negative Breast Cancer. Int J Mol Sci 2023;24. [PMID: 36675313 DOI: 10.3390/ijms24021799] [Reference Citation Analysis]
6 Ueda K, Sakai C, Ishida T, Morita K, Kobayashi Y, Horikoshi Y, Baba A, Okazaki Y, Yoshizumi M, Tashiro S, Ishida M. Cigarette smoke induces mitochondrial DNA damage and activates cGAS-STING pathway: application to a biomarker for atherosclerosis. Clin Sci (Lond) 2023;137:163-80. [PMID: 36598778 DOI: 10.1042/CS20220525] [Reference Citation Analysis]
7 Bitenc M, Grebstad Tune B, Melheim M, Atneosen-Åsegg M, Lai X, Rajar P, Solberg R, Baumbusch LO. Assessing nuclear versus mitochondrial cell-free DNA (cfDNA) by qRT-PCR and droplet digital PCR using a piglet model of perinatal asphyxia. Mol Biol Rep 2023;50:1533-44. [PMID: 36512170 DOI: 10.1007/s11033-022-08135-0] [Reference Citation Analysis]
8 Kostyuk SV, Ershova ES, Martynov AV, Artyushin AV, Porokhovnik LN, Malinovskaya EM, Jestkova EM, Zakharova NV, Kostyuk GP, Izhevskaia VL, Kutsev SI, Veiko NN. In Vitro Analysis of Biological Activity of Circulating Cell-Free DNA Isolated from Blood Plasma of Schizophrenic Patients and Healthy Controls-Part 2: Adaptive Response. Genes (Basel) 2022;13. [PMID: 36553550 DOI: 10.3390/genes13122283] [Reference Citation Analysis]
9 Műzes G, Bohusné Barta B, Szabó O, Horgas V, Sipos F. Cell-Free DNA in the Pathogenesis and Therapy of Non-Infectious Inflammations and Tumors. Biomedicines 2022;10. [PMID: 36359370 DOI: 10.3390/biomedicines10112853] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Qian B, Li K, Lou X, Guo Y, Wang Y, Wu L, Zhang D. Plasma Cell-Free DNA as a Novel Biomarker for the Diagnosis and Monitoring of Atherosclerosis. Cells 2022;11:3248. [PMID: 36291116 DOI: 10.3390/cells11203248] [Reference Citation Analysis]
11 Daniels TE, Zitkovsky EK, Kunicki ZJ, Price DJ, Peterson AL, Dennery PA, Kao HT, Price LH, Tyrka AR, Abrantes AM. Associations of circulating cell-free DNA, C-reactive protein, and cardiometabolic risk among low-active smokers with elevated depressive symptoms. Brain Behav Immun Health 2022;25:100519. [PMID: 36164463 DOI: 10.1016/j.bbih.2022.100519] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Fathima N, Manorenj S, Vishwakarma SK, Khan AA. Cell-free mitochondrial DNA quantification in ischemic stroke patients for non-invasive and real-time monitoring of disease status. World J Transl Med 2022; 10(2): 14-28 [DOI: 10.5528/wjtm.v10.i2.14] [Reference Citation Analysis]
13 Demirci S. Urinary cell-free extrachromosomal circular DNAs: A possible biomarker for chronic kidney disease. Clin Transl Med 2022;12:e925. [PMID: 35678106 DOI: 10.1002/ctm2.925] [Reference Citation Analysis]
14 Futai N, Fukazawa Y, Kashiwagi T, Tamaki S, Sakai R, Hogan CA, Murugesan K, Ramachandran A, Banaei N, Santiago JG. A modular and reconfigurable open-channel gated device for the electrokinetic extraction of cell-free DNA assays. Analytica Chimica Acta 2022;1200:339435. [DOI: 10.1016/j.aca.2022.339435] [Reference Citation Analysis]
15 Kubota Y, Hatakeyama S, Yoneyama T, Yoneyama MS, Hamano I, Konishi S, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C. Prognostic significance of total plasma cell-free DNA level and androgen receptor amplification in castration-resistant prostate cancer. World J Urol 2021. [PMID: 33675416 DOI: 10.1007/s00345-021-03649-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Lau A, Ren C, Lee LP. Critical review on where CRISPR meets molecular diagnostics. Prog Biomed Eng 2021;3:012001. [DOI: 10.1088/2516-1091/abbf5e] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
17 Agiannitopoulos K, Samara P, Papadopoulou E, Tsamis K, Mertzanos G, Babalis D, Lamnissou K. Study on the admission levels of circulating cell-free DNA in patients with acute myocardial infarction using different quantification methods. Scand J Clin Lab Invest 2020;80:348-50. [PMID: 32077765 DOI: 10.1080/00365513.2020.1729400] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Chen A, Li J, Wang L, Huang Q, Zhu J, Wen S, Lyu J, Wu W. Comparison of paired cerebrospinal fluid and serum cell-free mitochondrial and nuclear DNA with copy number and fragment length. J Clin Lab Anal 2020;34:e23238. [PMID: 32052892 DOI: 10.1002/jcla.23238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
19 Wang D, Hu X, Long G, Xiao L, Wang ZM, Zhou LD. The clinical value of total plasma cell-free DNA in hepatitis B virus-related hepatocellular carcinoma. Ann Transl Med 2019;7:650. [PMID: 31930051 DOI: 10.21037/atm.2019.10.78] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]